Kim Blickenstaff - Tandem Diabetes Insider

Tandem Diabetes Care Inc -- USA Stock  

USD 2.89  0.01  0.35%

CEO and President and Director

Mr. Kim D. Blickenstaff is President, Chief Executive Officer, and Director of Tandem Diabetes Care, Inc. Prior to joining our company, he served as Chairman and Chief Executive Officer of Biosite Incorporated, or Biosite, a provider of medical diagnostic products, from 1988 until its acquisition by Inverness Medical Innovations, Inc. in June 2007. Mr. Blickenstaff currently serves as Chairman of Medivation, Inc., and is a member of its audit committee. He previously served as a director of DexCom, Inc., a provider of glucose monitoring systems, from June 2001 to September 2007
Age: 63  CEO Since 2007  MBA    
Blickenstaff was formerly a certified public accountant and has more than 20 years of experience overseeing the preparation of financial statements. He received a B.A. in Political Science from Loyola University, Chicago, and an M.B.A. from the Graduate School of Business, Loyola University, Chicago.

Kim Blickenstaff Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (46.76) % which means that it has lost $46.76 on every $100 spent on asset. This is way below average.
The company currently holds 75.6 M in liabilities with Debt to Equity (D/E) ratio of 8.6 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Tandem Diabetes Care Inc has Current Ratio of 1.86 which is within standard range for the sector.

Similar Executives

Found 1 records

CEO Since

Matt MolchanDigirad Corporation

Entity Summary

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various solutions for people with insulindependent diabetes in the United States. Tandem Diabetes Care Inc (TNDM) is traded on NASDAQ General Markets in USA. It is located in CALIFORNIA, U.S.A and employs 482 people. Tandem Diabetes is listed under Medical Equipment category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Tandem Diabetes Care Inc to your portfolio

Top Management

Tandem Diabetes Care Leadership Team
Brian Hansen, President, MBA
Fred Cohen, Director
Susan Morrison, Executive
Lori Gildea, President, MBA
Howard Greene, Director, MBA
Christopher Twomey, Director
Henry Anhalt, Director
Edward Cahill, Director
Lonnie Smith, Chairman, MBA
John Cajigas, CFO
Dick Allen, Chairman, MBA
David Berger, Executive
Jesse Treu, Director, Ph.D
Douglas Roeder, Director
Leigh Vosseller, President
John Sheridan, COO, MBA
Kim Blickenstaff, CEO, MBA
Robert Anacone, EVP

Stock Performance

Tandem Diabetes Performance Indicators